Fayez Sarofim & Co Portfolio holdings
AUM
$41.7B
1-Year Return
15.12%
This Quarter Return
+0.3%
1 Year Return
+15.12%
3 Year Return
+67.65%
5 Year Return
+130.07%
10 Year Return
+262.45%
AUM
$41.1B
AUM Growth
+$1.81B
(+4.6%)
Cap. Flow
+$2.06B
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
42.56%
Holding
315
New
30
Increased
123
Reduced
65
Closed
3
Top Buys
| 1 |
NVIDIA
NVDA
|
$264M |
| 2 |
Deere & Co
DE
|
$143M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$128M |
| 4 |
JPMorgan Chase
JPM
|
$118M |
| 5 |
Chevron
CVX
|
$84.4M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$71.6M |
| 2 |
Comcast
CMCSA
|
$32.6M |
| 3 |
Union Pacific
UNP
|
$18.6M |
| 4 |
HES
Hess
HES
|
$18.2M |
| 5 |
Kemper
KMPR
|
$17.7M |
Sector Composition
| 1 | Technology | 30.18% |
| 2 | Financials | 18.99% |
| 3 | Healthcare | 11.19% |
| 4 | Consumer Staples | 11.19% |
| 5 | Energy | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
CVS Health
CVS
$93.5B
| $371K | ﹤0.01% |
8,273
-1,200
| -13% | -$53.9K |
|
252
Virginia National Bankshares
VABK
$218M
| $359K | ﹤0.01% |
9,402
-317
| -3% | -$12.1K |
|
253
Halozyme
HALO
$8.59B
| $359K | ﹤0.01% |
+7,500
| New | +$359K |
|
254
Arista Networks
ANET
$177B
| $355K | ﹤0.01% |
3,216
-200
| -6% | -$22.1K |
|
255
United Rentals
URI
$62.1B
| $352K | ﹤0.01% |
500
| – | – |
|
256
Biogen
BIIB
$20.5B
| $352K | ﹤0.01% |
2,300
| – | – |
|
257
Trane Technologies
TT
$91.9B
| $352K | ﹤0.01% |
+952
| New | +$352K |
|
258
Carlyle Group
CG
$23.5B
| $346K | ﹤0.01% |
6,849
| – | – |
|
259
iShares Core S&P Small-Cap ETF
IJR
$85.7B
| $345K | ﹤0.01% |
2,996
| – | – |
|
260
Xylem
XYL
$34.5B
| $344K | ﹤0.01% |
+2,964
| New | +$344K |
|
261
Micron Technology
MU
$139B
| $343K | ﹤0.01% |
4,078
| – | – |
|
262
Bristow Group
VTOL
$1.08B
| $343K | ﹤0.01% |
+10,000
| New | +$343K |
|
263
CrowdStrike
CRWD
$104B
| $342K | ﹤0.01% |
1,000
| – | – |
|
264
New Mountain Finance
NMFC
$1.13B
| $341K | ﹤0.01% |
30,272
| – | – |
|
265
Nomad Foods
NOMD
$2.24B
| $336K | ﹤0.01% |
+20,000
| New | +$336K |
|
266
Bristol-Myers Squibb
BMY
$95B
| $334K | ﹤0.01% |
5,898
| – | – |
|
267
Dow Inc
DOW
$16.9B
| $332K | ﹤0.01% |
8,280
| – | – |
|
268
Hilton Worldwide
HLT
$65.4B
| $330K | ﹤0.01% |
1,336
| – | – |
|
269
WK Kellogg Co
KLG
$1.98B
| $324K | ﹤0.01% |
17,993
-665
| -4% | -$12K |
|
270
Organon & Co
OGN
$2.52B
| $322K | ﹤0.01% |
21,595
-8,204
| -28% | -$122K |
|
271
Powell Industries
POWL
$3.27B
| $321K | ﹤0.01% |
+1,450
| New | +$321K |
|
272
iShares Russell 2000 ETF
IWM
$67.4B
| $310K | ﹤0.01% |
1,404
+1
| +0.1% | +$221 |
|
273
KLA
KLAC
$115B
| $310K | ﹤0.01% |
492
-175
| -26% | -$110K |
|
274
Marsh & McLennan
MMC
$101B
| $308K | ﹤0.01% |
1,450
| – | – |
|
275
American Electric Power
AEP
$58.1B
| $300K | ﹤0.01% |
3,250
-300
| -8% | -$27.7K |
|